Rexahn Pharmaceuticals CEO Douglas Swirsky's 2020 pay jumps 142% to $1.6M
Rexahn Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 26, 2021
Rexahn Pharmaceuticals reported fiscal year 2020 executive compensation information on April 26, 2021.
In 2020, four executives at Rexahn Pharmaceuticals received on average a compensation package of $606K, a 7% decrease compared to previous year.
Average pay of disclosed executives at Rexahn Pharmaceuticals
Douglas J. Swirsky, Chief Executive Officer, received $1.6M in total, which increased by 142% compared to 2019.
Mina Sooch, Chief Executive Officer, received a compensation package of $483K. 77% of the compensation package, or $370K, was in option awards.
Amy Rabourn, Vice President of Finance, earned $267K in 2020.
Bernhard Hoffmann, Vice President of Corporate Development and Operations, received $102K in 2020.
Related executives
You may also like
Source: SEC filing on April 26, 2021.